Aug 11, 2026 04:05PM

May 12, 2026 05:03PM

Mar 5, 2026 04:05PM

Nov 12, 2025 04:05PM

Aug 13, 2025 06:48AM

Aug 11, 2025 04:30PM

Aug 11, 2025 04:30PM BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition

28,552 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All